glp 1 drugs menopause and GLP-1 weight-loss could cause bone loss Top 5 Menopause GLP-1 Weight

GIP receptor activation may contribute to improved metabolic function, while GLP-1 receptor agonism primarily mediates appetite suppression through central nervous system pathways affecting satiety centers in the hypothalamus

Quality matters enormously: Reliable indicators: Third-party testing certificates Proper lyophilised (freeze-dried) form Clear labelling with batch numbers Stored and shipped refrigerated Reasonable pricing (not too cheap) Red flags: Liquid forms (less stable) No testing documentation Extremely low prices "Research chemical" disclaimers only Shipped from certain countries without quality control Legal Status UK Both exist in same grey area: Not approved medicines Not controlled substances Legal to possess Sold for "research" Some clinics prescribe off-label WADA bans both for competitive athletes

Jafari, S., Maleki Dizaj, S

Research Grant Support- Intercept, Galectin, BMS, Novo Nordisk, Viking, Pfizer